TrialBreast cancer research and treatment2018

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.

Luc Y Dirix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.